prior relapsers

Related by string. * priors . Priors . PRIOR . p rior . Prior : F CAST PRIOR . Prior Owais Shah . prior written consent . Prior Written Consent . validly withdrawn prior . Prior Sussex wkt . Prior wk . prior . PRIOR TO REGISTRATION OR . Arranged Prior To . without Fena prior . Prior thereto . JON PRIOR . Restate Prior . By RICHARD PRIOR . Cassie Busse Prior . Matt Prior wkt / : relapsers * *

Related by context. Frequent words. (Click for all words.) 62 nonresponders 60 evaluable 59 sustained virologic response 58 FOLFIRI 58 peginterferon alfa 2b 58 evaluable patients 57 RECIST criteria 57 P = .# 56 placebo p = 56 plus ribavirin 56 confidence interval #.#-#.# 55 plus methotrexate 55 seroconversion 55 p = #.# [004] 55 discontinuations due 55 tumor shrinkage 55 peginterferon alfa 2a 54 target lesion revascularization 54 HCV genotype 1 54 FOLFOX 54 imatinib 54 pegylated interferon 54 n = 54 metastatic renal cell carcinoma 54 confidence interval CI 54 adalimumab 54 Median survival 53 median PFS 53 nilotinib 53 events AEs 53 peginterferon 53 copies mL 53 HCV RNA 53 undetectable viral load 53 DMARDs 53 raltegravir 53 copies ml 53 infliximab 53 mg BID 52 prespecified 52 nasopharyngitis 52 HCV infected 52 p = 52 unfractionated heparin 52 dasatinib 52 laboratory abnormalities 52 decitabine 52 fluorouracil 52 reperfusion 52 RECIST 52 NNRTI 51 Secondary endpoints 51 HbA1c levels 51 Taxotere ® 51 randomized #:# 51 etanercept 51 leukopenia 51 composite endpoint 51 Secondary endpoints included 51 placebo p 51 NRTI 51 viral suppression 51 p = #.# [002] 51 LVEF 51 % CI #.#-#.# [006] 51 pruritus 51 events SAEs 51 Secondary endpoints include 51 ACR# [002] 51 dexamethasone 51 febrile neutropenia 51 placebo 51 XGEVA 51 hypokalemia 50 IU mL 50 dose cohorts 50 free survival PFS 50 adefovir 50 mcg kg 50 reoperation 50 diagnosed multiple myeloma 50 gefitinib 50 distant metastases 50 lamivudine 50 erythema 50 LMWH 50 topotecan 50 mitoxantrone 50 liver metastases 50 esomeprazole 50 fluticasone 50 target vessel revascularization 50 log# 49 bortezomib 49 linezolid 49 vertebral fracture 49 lopinavir 49 PROMACTA 49 mg dose 49 patients receiving ERBITUX 49 statistically significant p

Back to home page